PLGA公司
膜乳化
超声
膜
生物相容性
外体
药物输送
内体
微泡
纳米颗粒
纳米医学
化学
生物物理学
体内
纳米技术
材料科学
细胞
生物化学
生物
小RNA
生物技术
有机化学
色谱法
基因
作者
Chao Liu,Wei Zhang,Yike Li,Jianqiao Chang,Fei Tian,Fanghao Zhao,Yao Ma,Jiashu Sun
出处
期刊:Nano Letters
[American Chemical Society]
日期:2019-10-10
卷期号:19 (11): 7836-7844
被引量:253
标识
DOI:10.1021/acs.nanolett.9b02841
摘要
Using natural membranes to coat nanoparticles (NPs) provides an efficient means to reduce the immune clearance of NPs and improve their tumor-specific targeting. However, fabrication of these drug-loaded biomimetic NPs, such as exosome membrane (EM)- or cancer cell membrane (CCM)-coated poly(lactic-co-glycolic acid) (PLGA) NPs, remains a challenging task owing to the heterogeneous nature of biomembranes and labor-intensive procedures. Herein, we report a microfluidic sonication approach to produce EM-, CCM-, and lipid-coated PLGA NPs encapsulated with imaging agents in a one-step and straightforward manner. Tumor cell-derived EM-coated PLGA NPs consisting of both endosomal and plasma membrane proteins show superior homotypic targeting as compared to CCM-PLGA NPs of similar sizes and core-shell structures in both in vitro and in vivo models. The underlying mechanism is associated with a significantly reduced uptake of EM-PLGA NPs by macrophages and peripheral blood monocytes, revealing an immune evasion-mediated targeting of EM-PLGA NPs to homologous tumors. Overall, this work illustrates the promise of using microfluidic sonication approach to fabricate biomimetic NPs for better biocompatibility and targeting efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI